Mohammad AskarPublic working copy · medical review pending

Uveitis and endophthalmitis · 134

Uveitis and endophthalmitis: organise diagnosis and treatment

Describe the inflammatory phenotype, investigate the relevant causes and distinguish prevention from urgent treatment.

Public working copy · medical review pending. Source, translation and medical checks remain open. Read the limitations in the text and references. These educational materials do not replace individual medical assessment. Published: 2026-11-18T19:45:52+01:00. Internal project references lead to this notice. They are not publicly accessible primary sources; the source limitations remain stated in the text.

Use history and phenotype to select investigations. Exclude infection and masquerade disease before escalating immunosuppression; suspected endophthalmitis needs urgent specialist treatment. Guideline class does not establish an automatic treatment obligation.

Terminology and draft status

Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.

01Use guidelines with their methods and limits

S1 recommendations use informal expert consensus; S2k uses structured consensus, S2e systematic evidence assessment and S3 combines evidence and structured consensus. These classes describe development methods, not a hierarchy of legal duties or the certainty of every statement. Apply recommendations to the individual clinical situation and explain a justified deviation. 1 2

In an examination, explain the finding, differential diagnosis and next action rather than invoking an examiner’s authority. The original 2017 evidence-rating reference and the words “may” and “should” remain relevant to appraisal, but recommendation strength is not interchangeable with evidence certainty. The catalogue confirms the reference exists; its complete methods have not been appraised here. 1 2 3

02Let history and phenotype select the tests

Ask about joint symptoms and inflammatory back pain, tuberculosis or syphilis exposure, tick bites, travel and raw-meat exposure. Skin changes including erythema nodosum, bowel symptoms and neurological deficits may direct investigation for sarcoidosis, inflammatory bowel disease or other systemic disease; a clue raises a question rather than proving a cause. 1 4

Classify the anatomical site, course, laterality, granulomatous features and complications before ordering tests. The DOG short diagnostic guide lists differential blood count, CRP or ESR, renal/liver measures, electrolytes and syphilis serology as its basic block; HLA-B27, ACE/sIL-2R and chest imaging belong to selected phenotypes, not a compulsory panel for every patient. Additional IGRA/Quantiferon or neurological/CSF investigation needs a clinical indication. 1 4

03Distinguish infectious and non-infectious anterior disease

Grade anterior chamber inflammation and assess pressure, iris, keratic precipitates and posterior involvement. Topical anti-inflammatory treatment and cycloplegia may be appropriate for non-infectious anterior uveitis; recurrent or chronic disease may require steroid-sparing treatment according to activity, complications and systemic context. The original 045-022 reference is retained; its complete treatment algorithm and current version still need checking. 1 3 4

Unilateral pressure spikes, sectoral iris atrophy and keratic precipitates can suggest HSV, VZV or CMV; none alone identifies the virus. Stellate precipitates may suggest Fuchs uveitis, while a simple “fine precipitates = CMV” rule is unreliable. Where the result changes treatment, selected aqueous PCR can guide antiviral therapy; distinguish infection treatment from unopposed anti-inflammatory escalation. 1 3 4

04Coordinate systemic disease and protect the child’s vision

HLA-B27-associated uveitis with inflammatory back pain or other spondyloarthritis features warrants coordinated rheumatological assessment. The original trigger of chronic back pain beginning before age 45 is a referral clue, not a diagnosis or a mandatory identical pathway for every HLA-B27-positive result. Check the current DGRh criteria before presenting the original 2019 algorithm as current. 1 3

JIA-associated uveitis may be asymptomatic in a white eye and still threaten vision. Arrange risk-based slit-lamp screening: the original 3-month interval is relevant to higher-risk groups, not all children regardless of ANA, age, arthritis type or disease duration. Treatment may progress from topical therapy to methotrexate and selected biologic therapy such as adalimumab; the SYCAMORE trial does not make one drug sequence universal for every child. 1 3

Retinal vasculitis describes an ocular inflammatory pattern and is not synonymous with large-vessel vasculitis. Assess ischaemia, infection and systemic disease before choosing immunosuppression; suspected giant-cell arteritis with threatened vision needs its own urgent pathway. The original blanket instruction to give high-dose steroids for retinal vasculitis is unsafe without this distinction. 1 3 4

05Treat intermediate and posterior disease by threat and cause

In intermediate uveitis, document vitreous haze using a reproducible scale such as Nussenblatt and assess macular oedema and visual function. Preventing cystoid macular oedema matters, but haze alone is not the whole treatment target. Cryotherapy or pars plana vitrectomy belongs to selected indications or complications, not automatic treatment of every intermediate uveitis. 1 3 4

Posterior inflammation can damage retina and choroid and leave foveal scars. Assess location, activity, macular involvement and infection or masquerade disease before local or systemic therapy; bilateral involvement alone does not establish a need for immediate systemic immunomodulation. Escalate non-infectious disease according to visual threat, recurrence, complications and systemic assessment. 1 3 4

06Separate prophylaxis, sampling and emergency treatment

Intracameral cefuroxime at the end of cataract surgery is a prophylactic intervention, not treatment for established endophthalmitis. AWMF 067-009 is the S3 guideline on perioperative/periinterventional antibiotic prophylaxis, version 5.0 of December 2024; the original title “microbiological diagnostics” and date 2023 do not identify that current document. Confirm the ophthalmic recommendation, local protocol, formulation and contraindications before clinical use. 1 5

Suspected endophthalmitis requires urgent ophthalmic assessment, microbiological sampling where feasible and prompt treatment. Vitreous sampling often gives greater yield than aqueous alone, but specimen choice depends on the presentation and must not delay treatment; aqueous can be complementary, and suspected endogenous disease may need blood cultures and systemic investigation. Keep antibiotic treatment protocols separate from prophylaxis and from a generic steroid algorithm. 1 6

The 1995 EVS randomised 420 eyes with endophthalmitis within 6 weeks of cataract surgery or secondary lens implantation and followed outcomes for 9 months. In eyes with light-perception-only vision, immediate vitrectomy increased the proportions reaching 20/40 (33% versus 11%) and 20/100 (56% versus 30%) and reduced severe visual loss (20% versus 47%); it did not establish the same rule for every presenting acuity or cause. 6

EVS is historical randomised evidence, not a direct trial of current small-gauge surgery, post-injection, traumatic or endogenous infection, or eyes with no light perception. Its systemic-antibiotic result concerns the tested regimens, not every systemic antimicrobial indication. These limits prevent a universal “tap and inject” or “vitrectomy for all” conclusion. 6

07Keep the reference table clinically qualified

The table preserves all 10 original reference topics and their original dates while marking verified catalogue corrections. Dates identify documents, not proof of current validity; the full JIA, spondyloarthritis, vasculitis and anterior/posterior treatment recommendations still require source-level confirmation before publication. Structured reasoning and coordinated care are more useful than memorising an unsupported mandatory test panel. 1 3 4 5

Keep the reference table clinically qualified
TopicReferenceDate and access boundaryClinical use
HistoryDOG/BVA 24dOriginal 15.01.2025; catalogue 02/2025; full document pendingSystemic and exposure clues
Diagnostic approachDOG/BVA 24cOriginal 15.01.2025; footer/catalogue 10/2022; extracted text readBasic block and phenotype-directed tests
Non-infectious anterior uveitisS1 AWMF 045-022Original 2023; catalogue identity checked, full text pendingActivity and steroid-sparing indications
Viral anterior uveitisS1 AWMF 045-027Original 08/2022; catalogue identity checked, full text pendingPressure, iris, precipitates and selected PCR
Intermediate uveitisDOG/BVA 24aOriginal and catalogue 06/2020; full text pendingMacular oedema, vitreous haze and selected procedures
Posterior uveitisDOG/BVA 24bOriginal 08/2017; catalogue 09/2017; full text pendingCause, visual threat and foveal damage
Axial spondyloarthritisDGRh/AWMF S3 in originalOriginal 2019; current full criteria pendingCoordinate rheumatology for relevant symptoms
JIA uveitisS2k AWMF 045-012Original therapy 2019 and interdisciplinary 10/2022; full versions pendingRisk-based screening; topical, MTX and selected adalimumab
Large-vessel vasculitisS2k AWMF 060-007 in originalOriginal 08/2020; current full recommendations pendingDistinguish retinal vasculitis from systemic ischaemic emergency
Endophthalmitis prophylaxisS3 AWMF 067-009Original 2023; verified version 5.0, 12/2024; ophthalmic full text pendingCefuroxime prophylaxis differs from vitreous sampling and infection treatment
What are the main learning points?

Use history and phenotype to select investigations. Exclude infection and masquerade disease before escalating immunosuppression; suspected endophthalmitis needs urgent specialist treatment. Guideline class does not establish an automatic treatment obligation.

When is assessment urgent?

Rapid visual loss, severe pain, marked inflammation after surgery or injection, retinal necrosis or suspected ocular infection requires urgent assessment. Suspected giant-cell arteritis with visual ischaemia is a separate emergency; not every retinal vasculitis warrants immediate unselected steroids. Rapid visual loss, severe pain, marked inflammation, a pressure rise or suspected infection or neurological disease also needs urgent assessment.

References and access status

  1. 1
    Immutable original export; uveitis and endophthalmitis examination compendium

    Complete export read; original attribution and any recording/transcript or appointment not independently verified.

  2. 2
    AWMF: guideline methodology and individual applicability

    Official classification text and AWMF guideline overview read 15 November 2026; methodological guidance, not an ophthalmic treatment trial.

  3. 3
    BVA/DOG official guideline catalogue

    Catalogue entries, numbers and displayed dates read 15 November 2026. This verifies catalogue metadata, not every full guideline or its current validity.

  4. 4
    DOG: Kurzanleitung diagnostisches Vorgehen bei Uveitis

    Complete one-page extracted text read 15 November 2026; no PDF visual inspection yet. Filename says 15.01.2025; document footer and official catalogue say 10/2022. Its history cross-link says 24c although catalogue assigns history to 24d. Discrepancies retained.

  5. 5
    AWMF 067-009: perioperative and periinterventional antibiotic prophylaxis

    Official title/version announcement read 15 November 2026: S3, version 5.0, December 2024. Full ophthalmic recommendations and evidence report not appraised.

  6. 6
    Endophthalmitis Vitrectomy Study, 1995

    Complete PubMed abstract read 15 November 2026. Full article, protocol and supplements unread; historical randomised population and procedures limit extrapolation.